token,surprisal
car,14.387346267700195
�,15.381412506103516
�,12.458714485168457
s,8.073436737060547
 Vir,17.097761154174805
ality,9.183770179748535
 Engine,7.109501838684082
 helps,13.478289604187012
 companies,12.685445785522461
 find,5.924853801727295
 the,2.4386415481567383
 perfect,4.791276454925537
 product,8.899394035339355
 market,13.076028823852539
 fit,5.584481716156006
",",3.7451233863830566
 maximize,9.55561637878418
 customer,4.549897193908691
 retention,7.165559768676758
 &,9.04602336883545
 growth,6.247381210327148
 and,3.2169082164764404
 discover,10.662373542785645
 new,1.3937829732894897
 revenue,7.211861610412598
 streams,0.79181969165802
.,0.9104580283164978
"
",2.0808141231536865
"
",0.0005907953600399196
This,7.529189109802246
 engine,8.02646541595459
 is,2.0785577297210693
 based,6.014466762542725
 on,0.21087266504764557
 a,3.1533048152923584
 viral,13.27820110321045
 loop,13.614092826843262
 model,7.448534965515137
 of,5.045805931091309
 3,8.265568733215332
 main,6.030141830444336
 parts,6.239387035369873
:,0.8356503248214722
 Acquisition,15.14509105682373
",",1.622504711151123
 Activ,11.964009284973145
ation,0.03349410742521286
 and,2.0330522060394287
 Ret,7.621295928955078
ention,0.3069656193256378
.,0.4602448046207428
 Each,5.039048671722412
 of,2.262389659881592
 these,0.41120097041130066
 loops,10.017520904541016
 is,2.524750232696533
 then,7.728007793426514
 broken,7.692269802093506
 down,0.7467438578605652
 into,0.4157562255859375
 its,6.767670631408691
 4,8.052406311035156
 main,1.6239210367202759
 components,2.7368505001068115
:,1.1349716186523438
 Aud,8.586584091186523
ience,0.19403241574764252
",",1.0377317667007446
 Offer,10.437541961669922
",",1.5585331916809082
 Copy,12.314924240112305
 and,2.0128371715545654
 Call,8.00496768951416
-,7.771485805511475
To,5.280274868011475
-,0.03046460449695587
Action,0.5140794515609741
 (,2.8729116916656494
AT,9.887194633483887
O,4.4915547370910645
CC,12.207698822021484
).,1.1237549781799316
"
",1.6700947284698486
"
",0.0003585423983167857
Using,9.022168159484863
 this,2.3431808948516846
 growth,10.975180625915527
 framework,7.022317409515381
 as,8.287070274353027
 the,2.859102725982666
 structure,10.885787963867188
 for,2.080916404724121
 your,3.1075007915496826
 plan,10.723653793334961
 you,4.573599338531494
 should,6.780373573303223
 be,2.332840919494629
 able,0.13574782013893127
 to,0.011325886473059654
 create,4.771825313568115
 a,1.6405611038208008
 clear,7.821183681488037
 path,4.737374782562256
 for,2.404747486114502
 growth,4.16610050201416
 over,8.424095153808594
 the,2.0547897815704346
 next,1.7799217700958252
 3,3.7630672454833984
 months,3.6666808128356934
.,0.933368444442749
 In,5.622047424316406
 it,10.002874374389648
",",2.5022475719451904
 you,0.48723676800727844
 must,7.889289379119873
 include,7.777350425720215
 the,3.2599215507507324
 following,1.2410948276519775
:,2.302229404449463
"
",0.2031920701265335
"
",0.00021895053214393556
-,6.161907196044922
 An,5.944887161254883
 explanation,8.552395820617676
 of,0.25853270292282104
 your,2.7623045444488525
 platform,7.6264214515686035
",",2.7993898391723633
 who,9.786711692810059
 your,4.146304607391357
 target,2.2743067741394043
 audience,0.36522960662841797
 is,0.6686727404594421
 and,1.6091315746307373
 why,4.124594211578369
 you,1.464792013168335
 feel,7.98110294342041
 it,4.369020938873291
 has,5.937511444091797
 potential,4.814016342163086
 for,3.018562078475952
 significant,8.75456428527832
 growth,1.3240054845809937
.,1.3010884523391724
"
",0.3323146402835846
-,14.55678939819336
 Your,4.740453243255615
 90,14.560410499572754
-,2.63747239112854
day,0.21047590672969818
 plan,3.891549825668335
 of,5.461706161499023
 attack,9.701221466064453
 detailing,10.584664344787598
 how,2.1165895462036133
 you,1.2279093265533447
 would,6.073315143585205
 approach,5.632030487060547
 growth,7.002762317657471
 with,4.449145317077637
 a,3.6761419773101807
 clear,5.669626712799072
 timeline,5.779199123382568
"
",4.792137145996094
 ,20.485307693481445
 ,9.345345497131348
 ,1.4780665636062622
 -,5.944320201873779
 Use,8.415847778320312
 the,2.6738297939300537
 viral,9.249500274658203
 loop,2.74930477142334
 model,1.0235282182693481
 as,3.748450517654419
 the,2.3474349975585938
 structure,5.8339996337890625
 to,2.7405824661254883
 develop,5.839398384094238
 this,7.650919437408447
 plan,3.3583154678344727
 but,9.920722961425781
 also,2.1961863040924072
 feel,11.661006927490234
 free,0.8535540699958801
 to,0.0070671080611646175
 use,3.706717014312744
 the,2.6796984672546387
 other,6.9727582931518555
 Race,19.972373962402344
car,0.2476159781217575
 Fram,15.730514526367188
eworks,0.01632728986442089
 if,6.089507102966309
 you,0.4096693694591522
 think,6.168578147888184
 they,3.3384368419647217
�,25.116943359375
�,2.9290990829467773
ll,2.62481689453125
 be,1.5276240110397339
 helpful,3.6499080657958984
.,1.3901714086532593
"
",0.3073553442955017
-,14.58357048034668
 A,3.7611184120178223
 detailed,4.294277667999268
 explanation,5.127185821533203
 of,0.09407860785722733
 how,2.434321403503418
 you,2.032142400741577
�,10.86563491821289
�,0.056859131902456284
d,2.7576465606689453
 measure,7.12498140335083
 and,3.299420118331909
 track,4.297137260437012
 your,1.3451836109161377
 progress,6.603872299194336
 during,6.179074287414551
 those,7.468681335449219
 90,5.485429763793945
 days,0.08636348694562912
"
",3.206700086593628
-,9.66275405883789
 Lastly,13.267887115478516
",",0.40559086203575134
 please,7.103719234466553
 include,3.8017356395721436
 your,3.355419397354126
 contact,9.064412117004395
 information,0.6106467247009277
 and,2.455672264099121
 a,4.627153396606445
 link,2.9827775955200195
 to,0.1657128781080246
 your,1.084197998046875
 CV,9.254800796508789
.,2.8119540214538574
 We,5.996354103088379
�,7.174746513366699
�,0.28579315543174744
re,3.6383864879608154
 eager,9.345210075378418
 to,0.09528903663158417
 get,4.970738887786865
 in,3.961792230606079
 touch,0.10628334432840347
 with,0.3797457218170166
 you,0.22274278104305267
!,3.5132246017456055
"
",0.5937294363975525
"
",0.0007120118825696409
##,10.322218894958496
 Summary,11.64232063293457
"
",1.1571201086044312
"
",0.0003227615379728377
1,6.868544101715088
.,0.6230324506759644
 Increase,9.349417686462402
 sales,8.116560935974121
 from,6.632605075836182
 $,5.266962051391602
50,5.318513870239258
",",1.9722087383270264
000,0.024182811379432678
 to,0.7873501777648926
 $,0.10975687950849533
250,4.417058944702148
",",0.13334211707115173
000,0.0018239106284454465
 in,3.955219268798828
 three,5.8301568031311035
 months,0.7387129068374634
"
",1.7211402654647827
2,21.255836486816406
.,0.001738760038278997
 Use,6.945295810699463
 vir,10.835783004760742
ality,0.004558715969324112
 as,4.5072526931762695
 a,1.389175295829773
 main,10.362200736999512
 driver,5.591015815734863
 with,8.016712188720703
 physicians,23.010379791259766
 at,8.296241760253906
 its,9.686346054077148
 core,1.0319504737854004
"
",1.4343082904815674
3,17.632835388183594
.,0.001457515056245029
 Have,7.746311664581299
 a,2.016535758972168
 target,7.485620021820068
 audience,0.7787754535675049
 of,1.5996617078781128
 physicians,10.456463813781738
 for,7.435388088226318
 ADHD,15.62320613861084
 medication,8.21247386932373
"
",1.9753665924072266
"
",0.1954294592142105
###,7.512585163116455
 The,6.9038472175598145
 Brief,13.264774322509766
"
",5.004469394683838
"
",0.0002995388931594789
Ad,8.386811256408691
zen,14.71033763885498
ys,9.653969764709473
 X,10.750967979431152
R,5.228867530822754
-,4.289833068847656
OD,14.919920921325684
T,5.768002510070801
 is,3.0650386810302734
 a,1.336564540863037
 brand,5.970883846282959
 new,0.47922584414482117
 drug,9.256924629211426
 to,5.456433296203613
 the,6.288579940795898
 market,1.8386602401733398
 with,3.1808907985687256
 no,6.653103351593018
 sales,10.068248748779297
 yet,4.611574649810791
.,1.0427625179290771
 It,3.0106594562530518
 has,3.197040319442749
 an,5.628499984741211
 extremely,4.905556678771973
 strong,4.3793134689331055
 patent,7.251646041870117
 on,5.46528434753418
 the,2.2781455516815186
 molecule,8.359484672546387
 and,2.390255928039551
 has,2.4124438762664795
 already,3.2631278038024902
 been,1.113771915435791
 approved,2.2829129695892334
 by,1.52816903591156
 the,0.9427251219749451
 FDA,0.6414291262626648
 for,1.3556972742080688
 children,9.659746170043945
 and,3.136883497238159
 adults,0.9470598697662354
 with,2.3649258613586426
 ADHD,0.40133965015411377
 (,5.3865203857421875
Att,8.698360443115234
ention,0.1902032196521759
 Def,0.17283138632774353
icit,0.0016626541037112474
 Hyper,0.2010469138622284
activity,0.0037838465068489313
 Disorder,0.016287198290228844
).,1.1817752122879028
 The,2.9035542011260986
 brief,14.078964233398438
 was,5.664844036102295
 clear,15.852802276611328
",",4.476037502288818
 �,16.019439697265625
�,8.780671119689941
S,11.402803421020508
ell,8.548796653747559
 at,6.183509349822998
 least,3.9510748386383057
 $,2.2429399490356445
250,2.457508087158203
K,3.142591953277588
 of,4.0542521476745605
 Ad,3.7411069869995117
zen,0.011070582084357738
ys,0.007043689955025911
 in,6.062265872955322
 three,1.7112972736358643
 months,0.10513534396886826
�,3.723919630050659
�,12.531255722045898
.,4.075588226318359
"
",1.8034439086914062
"
",0.0003647353150881827
###,4.98283052444458
 The,2.321958303451538
 Challenge,9.430388450622559
"
",0.12511701881885529
"
",0.00022462682682089508
Ad,2.903040647506714
zen,0.014665467664599419
ys,0.006610311567783356
 X,1.7541974782943726
R,0.010766113176941872
-,0.09783229231834412
OD,0.018229709938168526
T,0.0022848781663924456
 is,1.2887086868286133
 a,1.8482067584991455
 brand,2.7776238918304443
 new,0.02291148714721203
 drug,0.24547016620635986
 to,1.1240421533584595
 the,0.008886137045919895
 market,0.016069795936346054
 with,0.17218467593193054
 no,0.04907715693116188
 sales,0.008504536002874374
 yet,0.002787003293633461
.,0.04096319526433945
 It,0.14366984367370605
 has,0.006338220555335283
 an,0.0060681672766804695
 extremely,0.035228703171014786
 strong,0.002924345200881362
 patent,0.005770881660282612
 on,0.005251750349998474
 the,0.0010888889664784074
 molecule,0.005279282107949257
 and,0.0027819201350212097
 has,0.008946790359914303
 already,0.0005923438584432006
 been,0.003245607018470764
 approved,0.003928957507014275
 by,0.16022320091724396
 the,0.0020063682459294796
 FDA,0.002157414797693491
 for,0.0017878350336104631
 children,0.026711221784353256
 and,0.008398664183914661
 adults,0.005716577172279358
 with,0.0015969685046002269
 ADHD,0.0006135065341368318
 (,0.028645986691117287
Att,0.005578969605267048
ention,0.062200650572776794
 Def,0.000555266859009862
icit,8.857378270477057e-05
 Hyper,0.0006344974972307682
activity,0.0074774581007659435
 Disorder,0.003679872490465641
).,0.029828092083334923
 The,0.3498143255710602
 brief,0.06401300430297852
 was,0.008526421152055264
 clear,0.004895786754786968
",",0.005316480528563261
 �,0.4482695758342743
�,0.006946306675672531
S,0.28769224882125854
ell,0.004815544933080673
 at,0.004755237139761448
 least,0.005965927615761757
 $,0.0025801537558436394
250,0.00395327340811491
K,0.0027484053280204535
 of,0.00338204437866807
 Ad,0.013417253270745277
zen,0.0006141947815194726
ys,0.006722445134073496
 in,0.0031936385203152895
 three,0.010355866514146328
 months,0.007108414079993963
�,0.026761503890156746
�,0.004800101276487112
.,0.005233712960034609
"
",1.3854639530181885
"
",0.0002895618381444365
###,1.625624656677246
 The,1.1028897762298584
 Solution,5.8342132568359375
"
",0.09269872307777405
"
",0.00019641756080091
The,3.9220638275146484
 biggest,9.548717498779297
 challenge,1.1779212951660156
 when,8.1627836227417
 launching,6.907960891723633
 a,1.7612172365188599
 new,0.9211465716362
 product,1.9696592092514038
 is,0.5939530730247498
 that,3.2060508728027344
 you,2.616584062576294
 have,1.84861159324646
 to,0.4097549319267273
 start,6.118916988372803
 from,2.358487129211426
 zero,6.219658851623535
.,1.0462514162063599
 We,5.522268772125244
 knew,8.476624488830566
 the,4.5481390953063965
 first,6.163126468658447
 sales,10.130340576171875
 would,3.9338111877441406
 come,1.9241520166397095
 from,1.345345377922058
 doctors,5.640209674835205
 that,6.066791534423828
 had,3.720125436782837
 a,5.080073356628418
 need,6.892327785491943
 for,0.36719179153442383
 ADHD,2.993602752685547
 med,9.346709251403809
s,0.03209884092211723
 and,2.5574870109558105
 we,3.060389995574951
 focused,8.793752670288086
 our,3.0948984622955322
 efforts,1.8018673658370972
 on,0.6002331376075745
 those,5.5824103355407715
.,3.709331512451172
 This,5.0995917320251465
 meant,5.943848609924316
 leveraging,9.985566139221191
 the,1.829087734222412
 patient,10.622774124145508
",",6.909075736999512
 parents,11.142260551452637
 and,1.0106626749038696
 caregivers,7.311196804046631
 as,3.4086384773254395
 an,5.719161510467529
 indirect,10.709291458129883
 channel,8.580215454101562
.,3.7828006744384766
"
",2.2331087589263916
"
",0.00027270425925962627
###,2.674800157546997
 The,1.1825999021530151
 Out,9.966836929321289
come,0.47548410296440125
"
",0.10186687111854553
"
",0.00020863003737758845
The,3.376715898513794
 first,3.073211908340454
 three,6.123105525970459
 months,0.43111738562583923
 were,2.632209062576294
 quite,7.050731182098389
 successful,4.734858512878418
 with,3.8848986625671387
 $,7.6694841384887695
268,13.251338958740234
K,1.2185155153274536
 sold,6.549953460693359
 and,2.999101400375366
 a,4.763005256652832
 15,8.384255409240723
%,0.43854597210884094
 market,4.450318336486816
 share,0.04619777202606201
 in,3.292865753173828
 just,6.339225769042969
 three,2.943571090698242
 months,0.18279635906219482
.,0.31687408685684204
